Company Filing History:
Years Active: 2022-2025
Title: The Innovative Work of Inventor Michael Asensio
Introduction
Michael Asensio is an accomplished inventor located in South San Francisco, California. With a focus on addressing critical health issues, he has made significant contributions through his patented innovations. Asensio holds three patents that specifically target viral infections, showcasing his dedication to improving public health.
Latest Patents
Among the significant patents held by Michael Asensio, two are particularly noteworthy. The first patent involves "Recombinant polyclonal proteins targeting Zika and methods of use thereof." This patent describes compositions that include recombinant polyclonal proteins derived from mammalian plasma cells and plasmablasts, specifically tailored for the Zika virus. The second patent focuses on "Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof." Similar to the first, this patent outlines the use of recombinant polyclonal proteins to combat COVID-19 and provides methods for their production and application in treating viral infections.
Career Highlights
Michael Asensio has had a fruitful career in which he contributed to various organizations, notably Gigagen, Inc. and Gigamune, Inc. Throughout his career, he has applied his expertise in immunology and virology to pioneer innovative solutions for complex health challenges. His work has positioned him as a valuable contributor in both the scientific and medical communities.
Collaborations
Throughout his journey, Michael collaborated with notable coworkers, including David Scott Johnson and Adam Shultz Adler. These collaborations have further enriched his work, allowing for the exchange of ideas and the development of groundbreaking innovations in the field of recombinant proteins.
Conclusion
In summary, Michael Asensio is a visionary inventor whose work has had a profound impact on the fight against viral infections. His innovative patents targeting Zika and COVID-19 demonstrate his dedication to fostering advancements in medical science. Asensio's contributions continue to inspire future research and innovation, underscoring the importance of collaboration in the ever-evolving landscape of health technology.